Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,640.1
-12.5 (-0.47%)

 

  • STI Straits Times Index
    2,640.1
    -12.5 (-0.47%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,603.3
    11.4 (0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,727.4
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,383.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,627.1
    336.3 (1.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,031.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 295.7M
  • Value: 185.3M
  • Rise: 121
  • Fall: 78
  • Unch: 609

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.001-
Clearbridge0.200+0.015
Oceanus^0.007+0.001
Singapore-eDev0.129-0.001
Adventus0.026+0.001
Biolidics0.515+0.105
AsiaMedic0.031-
Medtecs Intl0.955+0.085
CSC0.020+0.001
Addvalue Tech0.028+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

RAPT THERAPEUTICS INC RAPT THERAPEUTICS
Updated on 10 Jul 2020 (End of trading day)
Last (USD): 25.460 Change: -1.030 High: 27.370 Remarks: -
Change (%): -3.89 Low: 25.340
Open 26.480 Yesterday's Close 26.490000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 113,527 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.76407 Trailing EPS (USD) e -1.92634 NAV (USD) b 5.4128
PE a - Trailing PE f - Price / NAV b 4.7037
Dividend (USD) d - Cash In Hand (USD) g 3.7552 Issued & Paid-up Shares c 24,373,700
Dividend Yield (%) d - Price / Cash In Hand g 6.780 Treasury Shares h -
Market Cap (M) 620.554 Enterprise Value (M) 482.355
Piotroski F Score 1 Exchange Code RAPT Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 52.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Jul 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference RAPT THERAPEUTICS INC NASDAQ 620.554 - - 4.7037 -
Industry Biotechnology NASDAQ 2,964.263 370.178 6455.431 7.1605 0.643
Local Peer AMGEN INC NASDAQ 146,497.033 18.681 19.088 15.4451 2.341
Local Peer GILEAD SCIENCES INC NASDAQ 95,733.518 17.775 19.293 4.3383 3.333
Local Peer VERTEX PHARMACEUTICAL NASDAQ 76,344.113 64.874 50.528 11.8150 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 69,860.390 33.018 30.650 5.7579 -
Local Peer ILLUMINA INC NASDAQ 54,426.750 54.318 57.778 11.7426 -
Local Peer BIOGEN INC NASDAQ 45,509.591 7.729 7.741 3.6272 -
Local Peer SEATTLE GENETICS INC NASDAQ 30,180.334 - - 17.0933 -
Local Peer MODERNA INC NASDAQ 24,344.271 - - 14.8361 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,030.394 9.995 10.122 2.0455 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 22,796.312 - 199.957 7.0360 -
Local Peer INCYTE CORPORATION NASDAQ 22,771.995 50.955 - 11.7519 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 18,629.383 - - 13.8023 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NOVAVAX INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KODIAK SCIENCES INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), UNIQURE N.V. (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), XENCOR INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANTKWEST INC (NASDAQ), VERACYTE INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), COMPUGEN (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VBI VACCINES INC CDA (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PRECIGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOGEN INC (NASDAQ), OMEROS CORP (NASDAQ), AKOUOS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), GERON CORP (NASDAQ), AGENUS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AVROBIO INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PERSONALIS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PROTHENA CORP PLC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KAMADA (NASDAQ), IVERIC BIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AFFIMED N V (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), VERASTEM INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CHIMERIX INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), ARAVIVE INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TREVENA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INFLARX N V (NASDAQ), ORGENESIS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RECRO PHARMA INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SESEN BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), SYNLOGIC INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), COHBAR INC (NASDAQ), CURIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), PRECIPIO INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ)
Global Peer CSL ASX 128,209.816 47.787 44.259 14.8247 0.939
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,610.839 25.780 40.426 5.7909 0.734
Global Peer WUXI BIO HKEx 196,902.869 171.283 171.284 13.7689 -
Global Peer SINO BIOPHARM HKEx 192,114.509 62.592 63.166 5.5449 0.522
Global Peer BEIGENE HKEx 118,747.020 - - 5.4478 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,940.272 90.648 72.544 4.5965 -
Global Peer 3SBIO HKEx 33,407.055 30.257 30.257 3.1029 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 30,590.881 - - 10.2558 -
Other Global Peers HAOHAI BIOTEC (HKEx), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MYOVANT SCIENCES LTD (NYSE), MESOBLAST LTD (ASX), ARCUS BIOSCIENCES INC (NYSE), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), IBIO INC (NYSE American), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), BIOTRON (ASX), ORAGENICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), BIOSINO BIO-TEC (HKEx), GENETIC TECHNOLOGIES (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), Suntar Eco-City (SGX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.590
-9.23 %
10 Days --2.090
-7.59 %
20 Days -+3.940
+18.31 %
Medium Term Return 3 Months -+8.270
+48.11 %
6 Months --2.720
-9.65 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 10.520 - 51.209 Change From 1 Year Low +14.940 % Change From 1 Year Low (%) +142.02
Change From 1 Year High -25.750 % Change From 1 Year High (%) -50.28
2 Years Range 10.520 - 51.209 Change From 2 Years Low +14.940 % Change From 2 Years Low (%) +142.02
Change From 2 Years High -25.750 % Change From 2 Years High (%) -50.28
5 Years Range 10.520 - 51.209 Change From 5 Years Low +14.940 % Change From 5 Years Low (%) +142.02
Change From 5 Years High -25.750 % Change From 5 Years High (%) -50.28
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Jul 2020 26.480 27.370 25.340 25.460 113,527 -
09 Jul 2020 27.440 27.855 25.370 26.490 77,593 -
08 Jul 2020 26.630 27.870 26.560 27.300 82,841 -
07 Jul 2020 27.070 27.580 26.690 26.810 89,234 -
06 Jul 2020 28.070 28.930 27.000 27.290 117,525 -
02 Jul 2020 28.610 29.830 27.015 28.050 104,418 -
01 Jul 2020 28.610 29.440 26.050 27.740 96,732 -
30 Jun 2020 26.400 29.500 25.885 29.020 135,800 -
29 Jun 2020 27.470 27.900 24.770 26.600 121,258 -
26 Jun 2020 31.770 32.440 26.180 27.550 1,494,216 -
25 Jun 2020 29.450 35.300 29.340 32.180 251,207 -
24 Jun 2020 32.300 33.460 29.130 29.240 199,855 -
23 Jun 2020 32.420 33.540 31.730 32.850 207,909 -
22 Jun 2020 31.580 32.480 28.420 32.180 227,984 -
19 Jun 2020 28.470 32.980 27.900 32.180 338,087 -
18 Jun 2020 25.440 28.350 24.870 28.270 215,953 -
17 Jun 2020 21.990 25.880 21.990 25.390 214,881 -
16 Jun 2020 23.000 23.340 21.770 21.960 131,924 -
15 Jun 2020 20.950 23.000 20.827 22.670 215,524 -
12 Jun 2020 21.310 22.070 20.540 21.520 79,391 -
11 Jun 2020 22.790 22.965 20.122 21.240 111,944 -
10 Jun 2020 21.430 24.395 21.250 23.210 222,624 -
Summary
Current 2 Weeks
(26 Jun 2020 to 10 Jul 2020)
31.770 32.440 24.770 25.460 2,433,144 -
Previous 2 Weeks
(12 Jun 2020 to 25 Jun 2020)
21.310 32.440 20.540 32.180 2,082,715 -
4 Weeks from
(14 May 2020 to 11 Jun 2020)
14.610 32.440 14.170 21.240 2,997,463 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.